Changes in disease activity, lung function and quality of life in patients with refractory sarcoidosis after anti-TNF treatment.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	437-443
Number of pages	7
Journal	Expert Opinion on Orphan Drugs [E]
Volume	1
Issue number	6
DOIs	https://doi.org/10.1517/21678707.2013.797891
Publication status	Published - 2013

Access to Document

@article{4abf4e0bc4f74b329bde53a3b956be31,

title = "Changes in disease activity, lung function and quality of life in patients with refractory sarcoidosis after anti-TNF treatment.",

author = "N.A.J. Rijswijk and A.D.M. Vorselaars and H.J.T. Ruven and R.G.M. Keijzers and P. Zanen and I.H.E. Korenromp and J.C. Grutters",

year = "2013",

doi = "10.1517/21678707.2013.797891",

language = "English",

volume = "1",

pages = "437--443",

journal = "Expert Opinion on Orphan Drugs [E]",

issn = "2167-8707",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - Changes in disease activity, lung function and quality of life in patients with refractory sarcoidosis after anti-TNF treatment.

AU - Rijswijk, N.A.J.

AU - Vorselaars, A.D.M.

AU - Ruven, H.J.T.

AU - Keijzers, R.G.M.

AU - Zanen, P.

AU - Korenromp, I.H.E.

AU - Grutters, J.C.

PY - 2013

Y1 - 2013

U2 - 10.1517/21678707.2013.797891

DO - 10.1517/21678707.2013.797891

M3 - Article

SN - 2167-8707

VL - 1

SP - 437

EP - 443

JO - Expert Opinion on Orphan Drugs [E]

JF - Expert Opinion on Orphan Drugs [E]

IS - 6

ER -